CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $165,388 | -30.1% | 39,378 | 0.0% | 0.00% | – |
| Q4 2022 | $236,662 | +7.8% | 39,378 | +4.4% | 0.00% | – |
| Q3 2022 | $219,565 | -4.8% | 37,726 | -2.3% | 0.00% | – |
| Q2 2022 | $230,526 | -2.3% | 38,614 | -18.6% | 0.00% | – |
| Q2 2018 | $236,000 | +2260.0% | 47,439 | +1694.2% | 0.00% | – |
| Q1 2018 | $10,000 | +42.9% | 2,644 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | +600.0% | 2,644 | +787.2% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 298 | -59.2% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 731 | +34.6% | 0.00% | – |
| Q1 2017 | $2,000 | – | 543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,904,400 | $3,355,000 | 2.31% |
| BVF INC/IL | 6,929,690 | $5,955,000 | 0.65% |
| CAXTON CORP | 324,452 | $279,000 | 0.32% |
| NEA Management Company, LLC | 3,750,000 | $3,222,000 | 0.23% |
| Orbimed Advisors | 5,000,000 | $4,297,000 | 0.07% |
| Fosun International Ltd | 459,274 | $390,000 | 0.03% |
| Paloma Partners Management Co | 229,800 | $197,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 127,602 | $110,000 | 0.00% |
| LMR Partners LLP | 54,931 | $47,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,495 | $15,000 | 0.00% |